Angèle Gayet-Ageron
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
von Dach E, Bochud P, Kaiser L, Harbarth S, Rossel A, McCallin S, Lemmenmeier E, Kohler P, Huttner B, Gayet-Ageron A, Flury D, Cuvelier C, Prendki V, Brunel A, Albrich W, Huttner A. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. JAMA 2020; 323:2160-2169.
02.06.2020Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
02.06.2020JAMA 2020; 323:2160-2169
von Dach Elodie, Bochud Pierre-Yves, Kaiser Laurent, Harbarth Stephan, Rossel Anne, McCallin Shawna, Lemmenmeier Eva, Kohler Philipp, Huttner Benedikt, Gayet-Ageron Angèle, Flury Domenica, Cuvelier Clémence, Prendki Virginie, Brunel Anne-Sophie, Albrich Werner, Huttner Angela
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
Huttner A, Albrich W, Bochud P, Gayet-Ageron A, Rossel A, Dach E, Harbarth S, Kaiser L. PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia. BMJ Open 2017; 7:e017996.
13.07.2017PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
13.07.2017BMJ Open 2017; 7:e017996
Huttner Angela, Albrich Werner, Bochud Pierre-Yves, Gayet-Ageron Angèle, Rossel Anne, Dach Elodie von, Harbarth Stephan, Kaiser Laurent
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
Sculier D, Calmy A, Bernasconi E, Schmid P, Hirzel C, Fehr J, Cavassini M, Battegay M, Gayet-Ageron A, Swiss HIV Cohort Study. Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study. BMC Infect Dis 2017; 17:476.
06.07.2017Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
06.07.2017BMC Infect Dis 2017; 17:476
Sculier Delphine, Calmy Alexandra, Bernasconi Enos, Schmid Patrick, Hirzel Cédric, Fehr Jan, Cavassini Matthias, Battegay Manuel, Gayet-Ageron Angèle, Swiss HIV Cohort Study
The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland
Ribi C, Chizzolini C, von Kempis J, Stoll T, Spertini F, Otto P, Koenig K, Lindner G, Leimgruber A, Hunziker T, Hauser T, Eisenberger U, Dayer E, Cohen C, Gayet-Ageron A, Trendelenburg M, Swiss Systemic Lupus Erythematosus Cohort Study Group. The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland. Swiss Med Wkly 2014; 144:w13990.
07.08.2014The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland
07.08.2014Swiss Med Wkly 2014; 144:w13990
Ribi Camillo, Chizzolini Carlo, von Kempis Johannes, Stoll Thomas, Spertini François, Otto Petra, Koenig Katrin, Lindner Gregor, Leimgruber Annette, Hunziker Thomas, Hauser Thomas, Eisenberger Ute, Dayer Eric, Cohen Clemens, Gayet-Ageron Angèle, Trendelenburg Marten, Swiss Systemic Lupus Erythematosus Cohort Study Group
Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988-2008
Keiser O, Egger M, Bernasconi E, Schmid P, Battegay M, Christen A, Tissot F, Gayet-Ageron A, Hasse B, Brinkhof M, Spoerri A, for the Swiss HIV Cohort Study and the Swiss National Cohort. Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988-2008. The American journal of psychiatry 2009
15.12.2009Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988-2008
15.12.2009The American journal of psychiatry 2009
Keiser Olivia, Egger Matthias, Bernasconi Enos, Schmid Patrick, Battegay Manuel, Christen Anna, Tissot Frédéric, Gayet-Ageron Angèle, Hasse Barbara, Brinkhof Martin W G, Spoerri Adrian, for the Swiss HIV Cohort Study and the Swiss National Cohort
Antiretroviral treatment during pregnancy
Keiser O, Swiss HIV Cohort Study (SHCS), de Tejada B, Hirschel B, Drack G, Wunder D, Gremlich E, Brinkhof M, Rudin C, Gayet-Ageron A, Swiss Mother & Child HIV Cohort Study (MoCHiV). Antiretroviral treatment during pregnancy. AIDS (London, England) 2008; 22:2323-30.
12.11.2008Antiretroviral treatment during pregnancy
12.11.2008AIDS (London, England) 2008; 22:2323-30
Keiser Olivia, Swiss HIV Cohort Study (SHCS), de Tejada Begoña Martinez, Hirschel Bernard, Drack Gero, Wunder Dorothea, Gremlich Erika, Brinkhof Martin W G, Rudin Christoph, Gayet-Ageron Angèle, Swiss Mother & Child HIV Cohort Study (MoCHiV)
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
El Amari E, Hirschel B, Bernasconi E, Hirsch H, Vernazza P, Cavassini M, Furrer H, Mueller N, Erb P, Steffen I, Cathomas G, Baumann M, Gayet-Ageron A, Toutous-Trellu L, Swiss HIV Cohort Study. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS (London, England) 2008; 22:1019-28.
31.05.2008Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
31.05.2008AIDS (London, England) 2008; 22:1019-28
El Amari Emmanuelle Boffi, Hirschel Bernard, Bernasconi Enos, Hirsch Hans H, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Mueller Nicolas J, Erb Peter, Steffen Ingrid, Cathomas Gieri, Baumann Michele, Gayet-Ageron Angèle, Toutous-Trellu Laurence, Swiss HIV Cohort Study
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
Ananworanich J, Leduc D, Satchell C, Yerly S, Perrin L, Hill A, Perneger T, Phanuphak P, Furrer H, Cooper D, Ruxrungtham K, Hirschel B, Staccato Study Group, Bernasconi E, Vernazza P, Nüesch R, Gayet-Ageron A, Le Braz M, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawasdikul S, Sirivichayakul S, Cavassini M, Karrer U, Genné D, Swiss HIV Cohort Study. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Lancet 2006; 368:459-65.
05.08.2006CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
05.08.2006Lancet 2006; 368:459-65
Ananworanich Jintanat, Leduc Dominic, Satchell Claudette, Yerly Sabine, Perrin Luc, Hill Andrew, Perneger Thomas, Phanuphak Praphan, Furrer Hansjakob, Cooper David, Ruxrungtham Kiat, Hirschel Bernard, Staccato Study Group, Bernasconi Enos, Vernazza Pietro, Nüesch Reto, Gayet-Ageron Angèle, Le Braz Michelle, Prasithsirikul Wisit, Chetchotisakd Ploenchan, Kiertiburanakul Sasisopin, Munsakul Warangkana, Raksakulkarn Phitsanu, Tansuphasawasdikul Somboon, Sirivichayakul Sunee, Cavassini Matthias, Karrer Urs, Genné Daniel, Swiss HIV Cohort Study
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
Karrer U, Speck R, Weber R, Russotti M, Schmid P, Hirschel B, Gayet-Ageron A, Cavassini M, Battegay M, Elzi L, Furrer H, Ledergerber B, Swiss HIV Cohort Study. Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir. AIDS (London, England) 2005; 19:1987-94.
18.11.2005Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
18.11.2005AIDS (London, England) 2005; 19:1987-94
Karrer Urs, Speck Roberto F, Weber Rainer, Russotti Marina, Schmid Patrick, Hirschel Bernard, Gayet-Ageron Angèle, Cavassini Matthias, Battegay Manuel, Elzi Luigia, Furrer Hansjakob, Ledergerber Bruno, Swiss HIV Cohort Study